Valuation: Incyte Corporation

Market Cap 23.51B 20.67B 19.24B 17.67B 33.18B 2,254B 33.61B 229B 89.31B 1,113B 88.25B 86.35B 3,848B P/E 2026 *
66.9x
P/E 2027 * 15.8x
Enterprise Value 19.5B 17.14B 15.96B 14.66B 27.52B 1,870B 27.88B 190B 74.09B 923B 73.21B 71.63B 3,192B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.83x
Free-Float
98.11%
Yield 2026 *
-
Yield 2027 * -
1 day+1.13%
1 week+3.04%
Current month+5.13%
1 month+3.93%
3 months+24.51%
6 months+15.17%
Current year+20.65%
1 week 114.5
Extreme 114.505
120.71
1 month 110.56
Extreme 110.56
120.71
Current year 89.25
Extreme 89.25
120.71
1 year 69.7
Extreme 69.695
120.71
3 years 50.27
Extreme 50.27
120.71
5 years 50.27
Extreme 50.27
120.71
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
16/7/26 Free

EVP, Human Resources

39,018 0.0195%
16/7/26 Free

Principal Accounting Officer

6,913 0.0035%
16/7/26 Sell

Chief Technology Officer

-78,469 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%+3.04%+69.85%+90.12% 23.51B
+2.49%+0.11%+20.46%-9.64% 66.74B
-0.08%+3.28%+37.43%+203.98% 53.32B
+1.78%+54.50%+54.50%+54.50% 48.12B
+1.90%-5.62%-56.56%-55.72% 38.25B
-0.41%+0.93%+56.10%-23.20% 29.85B
+2.91%-5.29%+66.16%-52.46% 21.45B
+0.20%+4.12%+81.89%+161.72% 16.47B
+1.44%+0.22%+64.66%+126.78% 16.38B
-0.72%+7.86%+138.14%+208.92% 12.4B
Average +1.04%-0.38%+53.26%+70.50% 32.65B
Weighted average by Cap. +1.26%-0.12%+38.83%+56.22%

Financials

2026 *2027 *
Net sales 5.73B 5.04B 4.69B 4.31B 8.09B 550B 8.19B 55.75B 21.77B 271B 21.51B 21.05B 938B 6.21B 5.46B 5.08B 4.66B 8.76B 595B 8.87B 60.37B 23.58B 294B 23.3B 22.8B 1,016B
Net income 363M 319M 297M 273M 512M 34.81B 519M 3.53B 1.38B 17.19B 1.36B 1.33B 59.4B 1.51B 1.33B 1.24B 1.14B 2.14B 145B 2.16B 14.72B 5.75B 71.68B 5.68B 5.56B 248B
Net Debt -4.01B -3.52B -3.28B -3.01B -5.65B -384B -5.73B -38.98B -15.22B -190B -15.04B -14.72B -656B -5.93B -5.21B -4.85B -4.45B -8.36B -568B -8.47B -57.65B -22.52B -281B -22.25B -21.77B -970B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
28/07/26 USD 119.56 +1.61% 1,536,235
24/07/26 USD 117.67 +0.84% 1,207,106
23/07/26 USD 116.69 +0.78% 956,259
22/07/26 USD 115.79 -1.36% 998,480
21/07/26 USD 117.39 +1.50% 1,906,845
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
117.67USD
Average target price
114.55USD
Spread / Average Target
-2.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock